Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Long-term effects of psychedelic drugs

A systematic review

Datos Bibliográficos

ID23366641
AutoresJacob S Aday (0000-0003-0578-8530), Cayla M Mitzkovitz, Emily K Bloesch (0000-0002-9623-0497), Christopher C Davoli, A K Davis (0000-0003-4770-8893)
Año2020
Volumen113
Páginas179-189
Fecha de publicación2020-06-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaNeuroscience & Biobehavioral Reviews (JOURNAL)
Identificadores de la revistaISSN: 0149-7634 • E-ISSN: 1873-7528
EditorialElsevier BV (PUBLISHER)
DOI10.1016/j.neubiorev.2020.03.017
IdiomaEN
Citas recibidas51
Referencias citadas98
  • Embodied Transformation

    Open Access•Zinet Ritschel, Brady Wagoner•Integrative Psychological and…•2026

  • Baseline Power of Theta Oscillations Predicts Mystical-Type Experiences Induced by DMT in a Natural Setting

    Open Access•Enzo Tagliazucchi, Federico Zamberlán et al.•Frontiers in Psychiatry•2021

  • Mindset over molecule

    Open Access•Christina Chwyl, Angelica Spata et al.•BMC Psychology•2026

  • Consciousness alterations in a cohort of young Swiss men

    Open Access•Marianthi Deligianni, Marianthi Lousiana Deligianni et al.•Frontiers in Psychiatry•2023

  • Ayahuasca-induced personal death experiences

    Open Access•Jonathan David, José Carlos Bouso et al.•Frontiers in Psychiatry•2023

  • Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample

    Open Access•Christin Mellner, Micael Dahlén et al.•International Journal of…•2022

  • Psychedelic substitution

    Open Access•Nicolas G Glynos, Jacob S Aday et al.•Frontiers in Psychiatry•2024

  • Attitudes of European psychiatrists on psychedelics

    Open Access•Marija Franka Žuljević, Nando Breški et al.•Frontiers in Psychiatry•2024

  • Accept to change

    Open Access•Óscar Soto-Angona, Amanda Rodriguez-Urrutia et al.•Journal of Contextual Behavioral…•2025

  • Synergies in psychedelic-assisted therapy

    Open Access•Jonathan Stellmacher, Christopher Schmidt et al.•Frontiers in Psychiatry•2026

  • Relationship Between Naturalistic Psychedelic Use and Grandiose Narcissism

    Open Access•Anastasia Ruban, Paweł Orlowski et al.•International Journal of Psychology•2026

  • The Rising Use of LSD among Business Managers

    B A Korman•Substance Use & Misuse•2024

  • Psychotic-Like Experiences and Concurrent Substance Use Among People Who Use New Psychoactive Substances

    Venla Ellilä, Jonna Levola et al.•Substance Use & Misuse•2023

  • Psychedelic experiences and long-term spiritual growth

    Open Access•William A Schutt, Julie Exline et al.•Current Psychology•2024

  • Epidemiology of Hallucinogen Microdosing Among Young Adults in the United States

    Open Access•Katherine M Keyes, Yvonne Terry-McElrath et al.•Drug and Alcohol Review•2026

  • Existential feelings as a phenomenological framework for psychedelic therapy

    Open Access•Floris B Tijhuis, Sabrina Coninx et al.•Philosophical Psychology•2025

  • Psychedelics and environmental virtues

    Nin Kirkham, C Letheby•Philosophical Psychology•2024

  • Integration of the Psychedelic Experience Among Brazilians

    Ana Cláudia Mesquita Garcia, Lucas Oliveira Maia et al.•Journal of Psychoactive Drugs•2026

  • Self‐treatment with psychedelic substances for health and wellbeing in Aotearoa New Zealand

    Open Access•Chris Arnison, R Egan et al.•Kōtuitui New Zealand Journal of…•2025

  • Building Psychedelic Studies as an Interdisciplinary Academic Field

    Amy Bartlett, A Vallely et al.•International Journal for the…•2023

  • Altered States of Consciousness During Ceremonial San Pedro Use

    Open Access•Arne Bohn, Michiel H H Kiggen et al.•International Journal for the…•2022

  • Do Psychedelic Trips Open the Door to Messages from God, Spirits, Transcendent Realities, or the Devil? Links with Attitudes About Psychedelics, Opinions About Legalization, and Interest in Personal Use

    Julie Exline, William A Schutt et al.•International Journal for the…•2022

  • Investigating the relationship between changes in metaphysical beliefs and death anxiety following a significant psychedelic experience

    Open Access•Sam G Moreton, Noah N Barr et al.•Death Studies•2024

  • Validation of a French Version of the Mystical Experience Questionnaire with Retrospective Reports of the Most Significant Psychedelic Experience among French Users

    Baptiste Fauvel, Samuli Kangaslampi et al.•Journal of Psychoactive Drugs•2022

  • Effects of Ayahuasca on Gratitude and Relationships with Nature

    Jacob S Aday, Emily K Bloesch et al.•Journal of Psychoactive Drugs•2024

  • Shame, Guilt and Psychedelic Experience

    David S Mathai, Daniel E Roberts et al.•Journal of Psychoactive Drugs•2025

  • Psychedelic Experiences and Mindfulness are Associated with Improved Wellbeing

    Tianhong Tim Qiu, John Paul Minda•Journal of Psychoactive Drugs•2022

  • Healing Words

    Raymond Feng, Terence H W Ching et al.•Journal of Psychoactive Drugs•2023

  • Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States

    Open Access•A K Davis, Gabrielle Agin-Liebes et al.•Journal of Psychoactive Drugs•2021

  • Therapeutic-Like Context and Relational Support During Psychedelic Use Moderate Links Among Stress, Challenging Experiences, and Psychological Outcomes

    Open Access•Aaron D Cherniak, Pehr Granqvist et al.•Journal of Psychoactive Drugs•2026

  • Setting the Stage for the Inner Journey

    Stanisław Adamczyk, Małgorzata Paczyńska et al.•Journal of Psychoactive Drugs•2025

  • Vermont Primary Care Provider Perspectives on Psychedelics — A Cross-Sectional Study

    Josephine Yalovitser, jonah levine et al.•Journal of Psychoactive Drugs•2025

  • Spiritual Benefit from Cannabis

    Frederick J Heide, Tai Chang et al.•Journal of Psychoactive Drugs•2021

  • Exploring the Use of Psilocybin Therapy for Existential Distress

    Coryn E Mayer, Virginia Lebaron et al.•Journal of Psychoactive Drugs•2021

  • Personal Psychedelic Experience as a Training Qualification for Facilitators

    Ar Wilson-Poe, Adrianne R Wilson-Poe et al.•Journal of Psychoactive Drugs•2024

  • On the mushrooming reports of “quiet quitting”

    B A Korman•Journal of Psychoactive Drugs•2023

  • Racial Differences in Naturalistic Psychedelic Use — Motivations for Use, Communication with Health Care Providers, and Outcomes

    Open Access•Nicolas G Glynos, Mallet R Reid et al.•Journal of Psychoactive Drugs•2025

  • A scoping review of variations among psychedelic interventions for psychological suffering associated with the end of life

    Open Access•Sarah Kratina, Carol Strike et al.•Social Science & Medicine•2025

  • Consideraciones bioéticas, legales y clínicas en el uso terapéutico de la psilocibina para trastornos depresivos

    Open Access•Diego Borbón•Revista de Bioética y Derecho•2025

  • Finding consonance

    John Balch, Jordan Grafman et al.•Religion Brain & Behavior•2024

  • Utilizing Psychedelics to Enhance Well-Being

    Open Access•Samuel Thomson, Nikos Thomacos•Journal of Psychoactive Drugs•2025

  • The phases of self in transformative experiences

    Open Access•Barbara Neuhofer, Maria Laura Dulbecco•Annals of Tourism Research•2024

  • Increases in Aesthetic Experience Following Ayahuasca Use

    Open Access•Jacob S Aday, Emily K Bloesch et al.•Journal of Humanistic Psychology•2024

  • Classic psychedelic medicines for adolescent refractory mental health disease

    Open Access•Aly Shah Aziz•Journal of Psychedelic Studies•2026

  • Journeying into Right Relations

    Open Access•David Wrathall, Hannah Gosnell et al.•Action Research•2026

  • The Content, Consistency and Accuracy of Stereotypes About Recreational Users of Various Psychoactive Substances

    Open Access•Matthias Forstmann, Christina Sagioglou•European Journal of Social…•2025

  • Macrodosing to microdosing with psychedelics

    Open Access•Ayse Ceren Kaypak, Aviad Raz et al.•Transcultural Psychiatric…•2022

  • Psychedelics and the future evolution of humanity

    Open Access•Michael James Winkelman•Journal of Psychedelic Studies•2025

  • Psychedelic Mystical Experience

    Open Access•Ron Cole-Turner•Religions•2022

  • Secular Mysticism

    Open Access•Richard H Jones•Religions•2022

  • Experiences With Sacred Mushrooms and Psilocybin In Dialogue

    Open Access•Antonella Fagetti, Roberto E Mercadillo•Anthropology of Consciousness•2022

  • Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer

    Open Access•Roland R Griffiths, Matthew W Johnson et al.•Journal of Psychopharmacology•2016

  • Cessation and reduction in alcohol consumption and misuse after psychedelic use

    Open Access•Albert Garcia‐Romeu, A K Davis et al.•Journal of Psychopharmacology•2019

  • Survey study of challenging experiences after ingesting psilocybin mushrooms

    Open Access•Theresa M Carbonaro, Matthew P Bradstreet et al.•Journal of Psychopharmacology•2016

  • Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction

    Open Access•Matthew W Johnson, Albert Garcia-Romeu et al.•Journal of Psychopharmacology•2014

  • Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction

    Albert Garcia-Romeu, Albert Garcia‐Romeu et al.•Current Drug Abuse Reviewse•2015

  • Psilocybin with psychological support for treatment-resistant depression

    Open Access•Robin Carhart‐Harris, R L Carhart-Harris et al.•Psychopharmacology•2018

  • Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

    Open Access•Katherine A Maclean, Matthew W Johnson et al.•Journal of Psychopharmacology•2011

  • Psychedelics and connectedness

    Open Access•Robin Carhart‐Harris, R L Carhart-Harris et al.•Psychopharmacology•2018

  • Inclusion of people of color in psychedelic-assisted psychotherapy

    Open Access•Timothy I Michaels, Jennifer Purdon et al.•BMC Psychiatry•2018

  • Lysergic acid diethylamide (LSD) for alcoholism

    Open Access•Teri S Krebs, Pål-Ørjan Johansen•Journal of Psychopharmacology•2012

  • Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

    Open Access•Roland R Griffiths, William A Richards et al.•Psychopharmacology•2006

  • Psychedelics not linked to mental health problems or suicidal behavior

    Open Access•Pål-Ørjan Johansen, Teri Suzanne Krebs•Journal of Psychopharmacology•2015

  • Human hallucinogen research

    Open Access•MW Johnson, WA Richards et al.•Journal of Psychopharmacology•2008

  • Emotional breakthrough and psychedelics

    Open Access•Leor Roseman, Eline Haijen et al.•Journal of Psychopharmacology•2019

  • Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

    Charles S Grob, Alicia Danforth et al.•Archives of General Psychiatry•2011

  • Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors

    Open Access•Roland R Griffiths, Matthew W Johnson et al.•Journal of Psychopharmacology•2018

  • Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer

    Open Access•Stephen Ro, Stephen Ross et al.•Journal of Psychopharmacology•2016

  • Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

    Open Access•RR Griffiths, R R Griffiths et al.•Journal of Psychopharmacology•2008

  • Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population

    Open Access•Peter S Hendricks, Christopher B Thorne et al.•Journal of Psychopharmacology•2015

  • Survey of subjective "God encounter experiences"

    Open Access•Roland R Griffiths, Ethan S Hurwitz et al.•PLoS ONE•2019

  • Psychedelic therapy for smoking cessation

    Open Access•T Noorani, Albert Garcia-Romeu et al.•Journal of Psychopharmacology•2018

  • LSD-assisted psychotherapy for anxiety associated with a life-threatening disease

    Open Access•Peter Gasser, Katharina Kirchner et al.•Journal of Psychopharmacology•2015

  • Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder

    Francisco Moreno, Francisco A Moreno et al.•The Journal of Clinical Psychiatry•2006

  • Set and setting, psychedelics and the placebo response

    Open Access•Ido Hartogsohn•Journal of Psychopharmacology•2016

  • The entropic brain

    Open Access•Robin L Carhart-Harris, Robert Leech et al.•Frontiers in Human Neuroscience•2014

  • Psychedelics Promote Structural and Functional Neural Plasticity

    Open Access•Calvin Ly, Alexandra C Greb et al.•Cell Reports•2018

  • Long-term follow-up of psilocybin-facilitated smoking cessation

    Matthew W Johnson, Albert Garcia-Romeu et al.•The American Journal of Drug and…•2017

  • Psychedelics and the essential importance of context

    Open Access•Robin L Carhart-Harris, Leor Roseman et al.•Journal of Psychopharmacology•2018

  • Psilocybin with psychological support for treatment-resistant depression

    Open Access•Robin L Carhart-Harris, Mark Bolstridge et al.•The Lancet Psychiatry•2016

  • Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases

    Open Access•Peter Gasser, Dominique Holstein et al.•The Journal of Nervous and Mental…•2014

  • Psilocybin occasioned mystical-type experiences

    Open Access•Roland R Griffiths, Matthew W Johnson et al.•Psychopharmacology•2011

  • Psilocybin-assisted treatment for alcohol dependence

    Open Access•Michael P Bogenschutz, Alyssa A Forcehimes et al.•Journal of Psychopharmacology•2015

  • Preferred Reporting Items for Systematic Reviews and Meta-Analyses

    Open Access•David Moher, Alessandro Liberati et al.•Annals of Internal Medicine•2009

  • Prohibited or regulated? LSD psychotherapy and the United States Food and Drug Administration

    Open Access•Matthew Oram•History of Psychiatry•2016

  • Long-term psychological effects of LSD

    Spencer A McWilliams, Renee J Tuttle•Psychological Bulletin•1973

  • Human Hallucinogenic Drug Research in the United States

    Rick J Strassman•Journal of Psychoactive Drugs•1991

  • A Six-Month Prospective Evaluation of Personality Traits, Psychiatric Symptoms and Quality of Life in Ayahuasca-Naïve Subjects

    Paulo César Ribeiro Barbosa, Irene Maurício Cazorla et al.•Journal of Psychoactive Drugs•2009

  • Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being

    Open Access•Natasha L Mason, Elisabeth Mischler et al.•Journal of Psychoactive Drugs•2019

  • A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification

    A K Davis, Elise Renn et al.•Journal of Psychoactive Drugs•2018

  • Beyond LSD

    Jacob S Aday, Emily K Bloesch et al.•Journal of Psychoactive Drugs•2019

  • Hitting Highs at Rock Bottom’

    Erika Dyck•Social History of Medicine•2006

  • Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression

    Open Access•Rosalind Watts, Camilla Day et al.•Journal of Humanistic Psychology•2017

  • Patient Experiences of Psilocybin-Assisted Psychotherapy

    Open Access•Alexander Belser, Alexander B Belser et al.•Journal of Humanistic Psychology•2017

  • Subjective effectiveness of ibogaine treatment for problematic opioid consumption

    Open Access•A K Davis, Joseph P Barsuglia et al.•Journal of Psychedelic Studies•2017

Obras citantes distintas51
Citas por año10,2
Intervalo de citas2021 - 2026 (6)
Velocidad de citacióncurrent
Altamente citadoNo
Tipos de citaNeutras: 50
Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae